• Home
  • ACT Against Afib
  • Normal Sinus Rhythm: How Breaking The Afib Cycle Can Be The Best Chance At a Normal Life

Normal Sinus Rhythm: How Breaking the Afib Cycle Can Be The Best Chance at a Normal Life

Healthcare professional wearing scrubs

The critical importance of timing, technique, and teamwork in Afib intervention

Atrial fibrillation (Afib) is more than a rhythm disorder—it's a progressive disease that, if left untreated, can lead to heart failure, stroke, and diminished quality of life.1-2 For healthcare providers, the question isn't whether to treat Afib, but when and how to intervene for the best outcomes.

Early Intervention: A Window of Opportunity

The longer Afib persists, the harder it becomes to reverse. Structural and electrical remodeling of the atria makes rhythm control increasingly difficult.3-4 That's why early intervention—especially during cardiac surgery—is essential. For patients already in the OR, surgical ablation offers a unique opportunity to restore rhythm without additional procedures. However, Afib remains surgically undertreated.5

Why Sinus Rhythm Matters: The Life-Changing Impact of Normal Heart Rhythm

Restoring sinus rhythm isn't just about symptom relief—it's about fundamentally changing a patient's health trajectory and quality of life. The benefits of maintaining normal sinus rhythm extend far beyond what patients and even some physicians realize:

Immediate Physical Benefits:

Enhanced Cardiac Output and Exercise Capacity

  • Normal atrial contraction contributes 15–30% of ventricular filling.6
  • Patients experience improved exercise tolerance and reduced fatigue.7
  • Better oxygen delivery to vital organs improves overall physical function.

Symptom Resolution

  • Elimination of palpitations, chest discomfort, and irregular heartbeat sensations.
  • Improved sleep quality as patients no longer wake from rhythm disturbances.
  • Reduced anxiety related to unpredictable heart rhythm episodes.

Long-Term Health Outcomes:

Stroke Risk Reduction

  • Organized atrial contraction reduces blood stasis and clot formation.8
  • Even with continued anticoagulation, stroke risk decreases significantly.9
  • Potential for anticoagulation discontinuation in some patients after successful rhythm restoration.10

Heart Failure Prevention

  • Prevents the Afib-induced cardiomyopathy that leads to heart failure.11-12
  • Maintains optimal ventricular filling and cardiac efficiency.
  • Reduces hospitalizations for heart failure exacerbations.13

Survival Advantage

  • Patients who spend more time in sinus rhythm experience fewer hospitalizations, improved functional capacity, and better long-term survival.14-15
  • Studies show that restoring sinus rhythm during surgery can bring survival rates in line with patients who never had Afib.16
  • Most importantly: successful rhythm restoration can put patients back on the same life-expectancy curve as if they never had Afib.17

42%

Higher survival at 1 year32

31%

Higher survival at 5 year33

20%

Higher survival at 10 year16

Quality of Life Transformation

  • Patients regain the ability to perform daily activities without limitation.18
  • Potentially return to recreational activities and hobbies previously restricted by symptoms.
  • Improved cognitive function as brain perfusion stabilizes.19

The Progressive Nature of Untreated Afib

Without intervention, Afib creates a self-perpetuating cycle:

  • Irregular rhythm leads to atrial remodeling.
  • Structural changes make Afib more persistent.
  • Heart function progressively deteriorates.
  • Stroke risk continues to increase.
  • Quality of life steadily declines.

Breaking this cycle through rhythm restoration halts disease progression and reverses many of these negative effects.

Surgical Ablation: The Gold Standard

Concomitant surgical ablation during cardiac surgery is a Class I recommendation.22 Performing the Cox-Maze IV procedure, the gold standard in surgical ablation, offers up to 90% freedom from Afib.23

Studies have shown that restoring sinus rhythm during surgery improves survival rates—bringing them in line with patients who never had Afib.16

Up to

90%

Freedom from Afib34-38

Up to

70%

Freedom from Afib39-40

 

LAA Exclusion: A Critical Complement

Excluding the left atrial appendage (LAA) has always been an important part of the Cox Maze IV procedure and is also recommended by all major medical societies for patients undergoing cardiac surgery.24-25 It reduces stroke risk and complements ablation by eliminating the primary source of thrombus formation. Despite its benefits, LAAE is underutilized—performed in fewer than 30% of eligible patients.26

Hybrid AF™ Therapy: For Patients Not Undergoing Surgery

For patients with long-standing persistent Afib, who are not candidates for structural heart surgery, Hybrid AF Therapy offers a minimally invasive, two-stage solution. This Class II recommended approach combines epicardial and endocardial ablation with LAAE, mimicking the Cox-Maze lesion set.27

Hybrid AF Therapy has demonstrated:

  • 2x greater effectiveness in stopping atrial arrhythmias compared to catheter ablation alone.28
  • 2x higher likelihood of eliminating the need for Afib medications.28
  • Significant improvements in quality of life and symptom burden.29

Tailoring the Approach: Lesion Set Options to Fit Each Patient

Not all patients require a full Cox Maze IV lesion set. Depending on multiple variables, such as the underlying cardiac condition and type of Afib, surgeons can tailor the ablation strategy. There are options for cardiac surgeons that range from pulmonary vein isolation to a Box lesion set that isolates the left atrial posterior wall. However, efficacy increases with each additional lesion set, and the full Cox Maze IV remains the most effective.30

Post-Surgical Monitoring: The Role of Electrophysiology

After surgical ablation, rigorous follow-up is crucial. Electrophysiologists are best equipped to monitor patients (per Heart Rhythm Society guidelines), manage the 90-day blanking period, and perform touch-up ablations if needed.31 Without structured follow-up, patients can risk Afib recurrence and missed opportunities for optimization.

The Bottom Line: Treat Afib Like the Progressive Disease It Is

Afib is often dismissed as a nuisance arrhythmia, but the consequences of ignoring it in the operating room are serious. Whether through surgical ablation, Hybrid AF Therapy, or both, restoring sinus rhythm can dramatically improve survival, reduce stroke risk, and enhance quality of life.

The evidence is clear: patients deserve the opportunity to return to normal sinus rhythm and reclaim their lives.

It'll take collaboration and effort from everybody on the heart teams to shift the paradigm and treat Afib with the urgency and seriousness it deserves. Because when sinus rhythm is restored, lives are restored.

 

Dr. McCarthy discusses matching surgical ablation to the atrial fibrillation patient

PM-US-3773A-1025-G

  1. Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56-e528.
  2. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-847.
  3. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol. 2008;1(1):62-73.
  4. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54(2):230-246.
  5. Mehaffey JH, Haywood NS, Hawkins RB, et al. Barriers to atrial fibrillation ablation during mitral valve surgery. J Thorac Cardiovasc Surg. 2021;161(3):1012-1019.
  6. Rahimtoola SH, Ehsani A, Sinno MZ, et al. Left atrial transport function in myocardial infarction. Importance of its booster pump function. Am J Med. 1975;59(5):686-694.
  7. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358(25):2667-2677.
  8. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet. 2009;373(9658):155-166.
  9. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004;109(12):1509-1513.
  10. Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020;383(14):1305-1316.
  11. Cha YM, Wokhlu A, Asirvatham SJ, et al. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function. Circ Arrhythm Electrophysiol. 2011;4(5):724-732.
  12. Machino-Ohtsuka T, Seo Y, Ishizu T, et al. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. J Am Coll Cardiol. 2013;62(20):1857-1865.
  13. Marrouche NF, Brachmann J, Andresen D, et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 2018;378(5):417-427.
  14. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825-1833.
  15. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261-1274.
  16. Musharbash FN, Schill MR, Sinn LA, et al. Performance of the Cox-maze IV procedure is associated with improved long-term survival in patients with atrial fibrillation undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2018;155(1):159-170.
  17. Ad N, Damiano RJ Jr, Badhwar V, et al. Expert consensus guidelines: Examining surgical ablation for atrial fibrillation. J Thorac Cardiovasc Surg. 2017;153(6):1330-1354.
  18. Mark DB, Anstrom KJ, Sheng S, et al. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1275-1285.
  19. Poole JE, Bahnson TD, Monahan KH, et al. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. J Am Coll Cardiol. 2020;75(25):3105-3118.
  20. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119(5):448.e1-19.
  21. Gehi AK, Sears S, Walker TJ, et al. Psychosocial and clinical factors associated with repeat catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2006;17(10):1073-1077.
  22. Badhwar V, Rankin JS, Damiano RJ Jr, et al. The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. Ann Thorac Surg. 2017;103(1):329-341.
  23. Damiano RJ Jr, Schwartz FH, Bailey MS, et al. The Cox maze IV procedure: predictors of late recurrence. J Thorac Cardiovasc Surg. 2011;141(1):113-121.
  24. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2019;140(2):e125-e151.
  25. Whitlock RP, Vincent J, Blackall MH, et al. Left Atrial Appendage Occlusion Study III (LAAOS III). Can J Cardiol. 2013;29(11):1443-1447.
  26. Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing concomitant cardiac surgery. JAMA. 2018;319(4):365-374.
  27. Pison L, La Meir M, van Opstal J, et al. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2012;60(1):54-61.
  28. Mahapatra S, LaPar DJ, Kamath S, et al. Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and long-standing persistent atrial fibrillation with long-term follow-up. Ann Thorac Surg. 2011;91(6):1890-1898.
  29. Krul SP, Driessen AH, van Boven WJ, et al. Thoracoscopic video-assisted pulmonary vein antrum isolation, ganglionated plexus ablation, and periprocedural confirmation of ablation lesions: first results of a hybrid surgical-electrophysiological approach for atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4(3):262-270.
  30. McCarthy PM, Manjunath A, Kruse J, et al. Should paroxysmal atrial fibrillation be treated during cardiac surgery? J Thorac Cardiovasc Surg. 2013;146(4):810-823.
  31. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275-e444.
  32. Rankin, J.S., Lerner, D.J., Braid-Forbes, M.J. et al. (2017). One-year mortality and costs associated with surgical ablation for atrial fibrillation concomitant to coronary artery bypass grafting. Eur J Cardiothorac Surg, 52(3):471-477. doi:10.1093/ejcts/ezx126
  33. Iribarne, A., DiScipio, A.W., McCullough, J.N. et al. (2019). Surgical Atrial Fibrillation Ablation Improves Long-Term Survival: A Multicenter Analysis. Ann Thorac Surg, 107(1):135-142. doi:10.1016/j.athoracsur.2018.08.022
  34. Gaynor, S. L., Schuessler, R. B., Bailey, M. S., Ishii, Y., Boineau, J. P., Gleva, M. J., ... & Damiano Jr, R. J. (2005). Surgical treatment of atrial fibrillation: predictors of late recurrence. The Journal of Thoracic and Cardiovascular Surgery, 129(1), 104-111.
  35. McCarthy, P. M., Gerdisch, M., Philpott, J., Barnhart, G. R., Waldo, A. L., Shemin, R., ... & Calkins, H. (2022). Three-year outcomes of the postapproval study of the AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation Trial. The Journal of Thoracic and Cardiovascular Surgery, 164(2), 519-527.
  36. Weimar, T., Bailey, M. S., Watanabe, Y., Marin, D., Maniar, H. S., Schuessler, R. B., & Damiano Jr, R. J. (2011). The Cox-maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients. Journal of Interventional Cardiac Electrophysiology, 31(1), 47-54.
  37. Schill, M. R., Musharbash, F. N., Hansalia, V., Greenberg, J. W., Melby, S. J., Maniar, H. S., ... & Damiano Jr, R. J. (2017). Late results of the Cox-maze IV procedure in patients undergoing coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery, 153(5), 1087-1094.
  38. Ad, N., Holmes, S. D., Lamont, D., & Shuman, D. J. (2017). Left-sided surgical ablation for patients with atrial fibrillation who are undergoing concomitant cardiac surgical procedures. The Annals of Thoracic Surgery, 103(1), 58-65.
  39. Voeller, R. K., Bailey, M. S., Zierer, A., Lall, S. C., Sakamoto, S. I., Aubuchon, K., ... & Damiano Jr, R. J. (2008). Isolating the entire posterior left atrium improves surgical outcomes after the Cox maze procedure. The Journal of Thoracic and Cardiovascular Surgery, 135(4), 870-877.
  40. Gillinov, A. M., et al. (2006). Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. Annals of Thoracic Surgery, 82(2), 502–514.
PM-US-4856A-0827-G